Glaukos (GKOS) Amortization of Deferred Charges (2015 - 2026)
Glaukos' (GKOS) quarterly Amortization of Deferred Charges came in at $1.1 million in Q1 2026, up 0.65% year-on-year from $1.1 million in Q1 2025, and up 1.97% on a QoQ basis from $1.1 million in Q4 2025.
Glaukos (GKOS) Amortization of Deferred Charges (2015 - 2026) Analysis & Trends
Glaukos (GKOS) has 11 years of Amortization of Deferred Charges data on file, last reported at $1.1 million in Q1 2026.
- On a quarterly basis, Amortization of Deferred Charges rose 0.65% year-over-year to $1.1 million in Q1 2026; TTM through Mar 2026 was $4.3 million, a 487.45% increase from a year earlier, with the FY2025 full-year figure at $4.3 million, up 492.2% from the prior year.
- Amortization of Deferred Charges for Q1 2026 stood at $1.1 million, up from $1.1 million in the prior quarter.
- Over the last five years, Amortization of Deferred Charges for GKOS reached as high as $3.3 million in Q4 2023 and fell as low as -$476000.0 in Q2 2024.
- Historically, Amortization of Deferred Charges has averaged $867588.2 across 5 years, with a median of $1.1 million in 2025.
- Across the five-year window, Amortization of Deferred Charges sank 238.37% in 2024 and surged 1800.0% in 2025, its largest moves.
- Year by year, Amortization of Deferred Charges stood at $992000.0 in 2022, then jumped by 232.06% to $3.3 million in 2023, then plunged by 98.3% to $56000.0 in 2024, then jumped by 1800.0% to $1.1 million in 2025, then grew by 1.97% to $1.1 million in 2026.
- Per Business Quant data, the three most recent Amortization of Deferred Charges figures were $1.1 million in Q1 2026, $1.1 million in Q4 2025, and $1.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.73 Bn | 176.43 Bn | 6.27 Bn |
| 2 | Stryker | 129.05 Bn | 126.17 Bn | 3.81 Bn |
| 3 | Medtronic | 108.52 Bn | 99.30 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.63 Bn | 67.18 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.43 Bn | 44.76 Bn | 1.29 Bn |
| 6 | Dexcom | 28.36 Bn | 27.24 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.14 Bn | 25.85 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.89 Bn | 26.32 Bn | - |
| 9 | Koninklijke Philips | 24.25 Bn | 21.12 Bn | 2.07 Bn |
| 10 | Glaukos | 8.73 Bn | 8.63 Bn | 117.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.09 Mn |
| Mar 31, 2026 | 1.09 Mn |
| Dec 31, 2025 | 1.06 Mn |
| Dec 31, 2025 | 1.06 Mn |
| Sep 30, 2025 | 1.06 Mn |
| Sep 30, 2025 | 1.06 Mn |
| Jun 30, 2025 | 1.06 Mn |
| Jun 30, 2025 | 1.06 Mn |
| Mar 31, 2025 | 1.08 Mn |
| Mar 31, 2025 | 1.08 Mn |
| Dec 31, 2024 | 56,000.00 |
| Dec 31, 2024 | 56,000.00 |
| Sep 30, 2024 | 67,000.00 |
| Sep 30, 2024 | 67,000.00 |
| Jun 30, 2024 | -476,000.00 |
| Jun 30, 2024 | -476,000.00 |
| Mar 31, 2024 | 1.07 Mn |
| Mar 31, 2024 | 1.07 Mn |
| Dec 31, 2023 | 3.29 Mn |
| Dec 31, 2023 | 3.29 Mn |